Novel Coronavirus-19 (COVID-19) in the immunocompromised transplant recipient: #Flatteningthecurve
- PMID: 32233057
- PMCID: PMC7228206
- DOI: 10.1111/ajt.15890
Novel Coronavirus-19 (COVID-19) in the immunocompromised transplant recipient: #Flatteningthecurve
Abstract
Worldwide collaboration will be required to define viral pathogenesis, correlates of immunity, and biomarkers for progressive infection to optimize clinical care and to interrupt pandemic spread of SARS-CoV-2.
Keywords: antibiotic: antiviral; clinical decision-making; complication: infectious; cytokines/cytokine receptors; editorial/personal viewpoint; immunosuppression/immune modulation; infection and infectious agents - viral; infectious disease; organ transplantation in general.
References
-
- Munster VJ, Koopmans M, van Doremalen N, van Riel D, de Wit E. A novel coronavirus emerging in china – key questions for impact assessment. N Engl J Med. 2020;382:692–694. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous